Critics of the current SpaceX valuation argue that the company's stock price has been untethered from traditional financial metrics since its public debut. They contend that the initial rally was driven more by hype and limited share availability than by the company's underlying business economics. With the company reporting net losses and facing high capital expenditure requirements for its AI and space projects, skeptics believe the market has been overly optimistic about how quickly these investments will translate into sustainable profitability.
Accountability-focused observers point to the significant risks posed by the upcoming expiration of share lockup periods. Because only a small percentage of SpaceX's total shares were made available to the public at the IPO, the market has been susceptible to artificial price inflation due to scarcity. As insiders and early investors gain the ability to sell their holdings in the coming months, the influx of new shares could create substantial downward pressure on the stock, potentially leaving retail investors with significant losses.
Furthermore, the rise in short interest is seen as a rational response to a company that many believe is fundamentally overvalued. Critics argue that the gap between SpaceX's multi-trillion-dollar valuation and its actual revenue growth is too wide to bridge in the near term. They warn that investors are ignoring the risks associated with debt-funded infrastructure spending and the potential for broader market corrections to hit high-multiple tech stocks particularly hard.
For these skeptics, the recent slide below the IPO price is a necessary correction that exposes the flaws in the initial valuation. They caution that until the company can demonstrate a clear path to consistent earnings and manage the transition to a larger public float, the stock remains a high-risk asset. Investors are urged to look past the narrative of innovation and focus on the cold reality of the company's balance sheet and the competitive challenges ahead.